Microbial etiology of pneumonia: Epidemiology, diagnosis and resistance patterns

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Cilloniz, Catia ^a   Martin Loeches, Ignacio ^b   Garcia Vidal, Carolina ^c   Jose, Alicia San ^a   Torres, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b ST JAMES S HOSPITAL   (Ireland)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Diagnosis; Microbial etiology; Pneumonia

Indexed keywords

PANTON VALENTINE LEUKOCIDIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL VIRULENCE; BLOOD CULTURE; DISEASE SEVERITY; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PNEUMONIA; PREVALENCE; PSEUDOMONAS AERUGINOSA; REVIEW; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; URINALYSIS; AGING; CROSS INFECTION; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; MICROBIOLOGY; PATHOGENICITY; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED;

AGING; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; STREPTOCOCCUS PNEUMONIAE;

EID: 85007107199     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122120     Document Type: Review

References (89)

1. Murphy, S.L.; Kochanek, K.D.; Xu, J.; Arias, E. Mortality in the United States, 2014. NCHS Data Brief 2015, 229, 1–8.
2. World Health Organization (WHO). Pneumonia Fact Sheet; World Health Organization Report 2016; WHO: Geneva, Switzerland, 2016.
3. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance 2014; Antimicrobial Resistance Global Surveillance Report; WHO: Geneva, Switzerland, 2014.
4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385, 117–171.
5. Welte, T.; Torres, A.; Nathwani, D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012, 67, 71–79.
6. Jain, S.; Self, W.H.; Wunderink, R.G.; Fakhran, S.; Balk, R.; Bramley, A.M.; Reed, C.; Grijalva, C.G.; Anderson, E.J.; Courtney, D.M.; et al. Community-Acquired pneumonia requiring hospitalization among U.S. adults. N. Engl. J. Med. 2015, 373, 415–427.
7. Rozenbaum, M.H.; Mangen, M.J.; Huijts, S.M.; van der Werf, T.S.; Postma, M.J. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. Vaccine 2015, 33, 3193–3199.
8. Cilloniz, C.; Ewig, S.; Polverino, E.; Marcos, M.A.; Esquinas, C.; Gabarrus, A.; Mensa, J.; Torres, A. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011, 66, 340–346.
9. Cilloniz, C.; Ewig, S.; Polverino, E.; Marcos, M.A.; Prina, E.; Sellares, J.; Ferrer, M.; Ortega, M.; Gabarrus, A.; Mensa, J.; et al. Community-acquired pneumonia in outpatients: Aetiology and outcomes. Eur. Respir. J. 2012, 40, 931–938.
10. Garau, J.; Baquero, F.; Perez-Trallero, E.; Perez, J.L.; Martin-Sanchez, A.M.; Garcia-Rey, C.; Martin-Herrero, J.E.; Dal-Re, R. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin. Microbiol. Infect. 2008, 14, 322–329.
11. Barlow, G.; Nathwani, D.; Williams, F.; Ogston, S.; Winter, J.; Jones, M.; Slane, P.; Myers, E.; Sullivan, F.; Stevens, N.; et al. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 2007, 62, 67–74.
12. Yu, K.T.; Wyer, P.C. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann. Emerg. Med. 2008, 51, 651–662.
13. Rozenbaum, M.H.; Pechlivanoglou, P.; van der Werf, T.S.; Lo-Ten-Foe, J.R.; Postma, M.J.; Hak, E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: A meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 305–316.
14. Simonetti, A.F.; Garcia-Vidal, C.; Viasus, D.; Garcia-Somoza, D.; Dorca, J.; Gudiol, F.; Carratala, J. Declining mortality among hospitalized patients with community-acquired pneumonia. Clin. Microbiol. Infect. 2016.
15. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults—United States, 2011. MMWR Morb. Mortal. Wkly. Rep. 2012, 61, 889–894.
16. Garcia-Vidal, C.; Ardanuy, C.; Tubau, F.; Viasus, D.; Dorca, J.; Linares, J.; Gudiol, F.; Carratala, J. Pneumococcal pneumonia presenting with septic shock: Host- and pathogen-related factors and outcomes. Thorax 2010, 65, 77–81.
17. Blasi, F. Atypical pathogens and respiratory tract infections. Eur. Respir. J. 2004, 24, 171–181.
18. Marrie, T.J.; Costain, N.; La, S.B.; Patrick, W.; Forgie, S.; Xu, Z.; McNeil, S.A. The role of atypical pathogens in community-acquired pneumonia. Semin. Respir. Crit. Care Med. 2012, 33, 244–256.
19. Cilloniz, C.; Torres, A.; Niederman, M.; van der, E.M.; Chalmers, J.; Welte, T.; Blasi, F. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016.
20. Basarab, M.; Macrae, M.B.; Curtis, C.M. Atypical pneumonia. Curr. Opin. Pulm. Med. 2014, 20, 247–251.
21. Capelastegui, A.; Espana, P.P.; Bilbao, A.; Gamazo, J.; Medel, F.; Salgado, J.; Gorostiaga, I.; Lopez de Goicoechea, M.J.; Gorordo, I.; Esteban, C.; et al. Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infect. Dis. 2012, 12, 134.
22. Cilloniz, C.; Ewig, S.; Ferrer, M.; Polverino, E.; Gabarrus, A.; Puig de la, B.J.; Mensa, J.; Torres, A. Community-acquired polymicrobial pneumonia in the intensive care unit: Aetiology and prognosis. Crit. Care 2011, 15, R209.
23. Ruuskanen, O.; Lahti, E.; Jennings, L.C.; Murdoch, D.R. Viral pneumonia. Lancet 2011, 377, 1264–1275.
24. Archer, B.; Cohen, C.; Naidoo, D.; Thomas, J.; Makunga, C.; Blumberg, L.; Venter, M.; Timothy, G.; Puren, A.; McAnerney, J.; et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: Epidemiology and factors associated with fatal cases. Euro Surveill 2009, 14.
25. Crovari, P.; Gasparini, R. Influenza (AH1N1v) pandemic 2009: An update. J. Prev. Med. Hyg. 2009, 50, 129–130.
26. Dowell, S.F.; Anderson, L.J.; Gary, H.E., Jr.; Erdman, D.D.; Plouffe, J.F.; File, T.M., Jr.; Marston, B.J.; Breiman, R.F. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Infect. Dis. 1996, 174, 456–462.
27. Zambon, M.C.; Stockton, J.D.; Clewley, J.P.; Fleming, D.M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: An observational study. Lancet 2001, 358, 1410–1416.
28. Griffin, M.R.; Coffey, C.S.; Neuzil, K.M.; Mitchel, E.F., Jr.; Wright, P.F.; Edwards, K.M. Winter viruses: Influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch. Intern. Med. 2002, 162, 1229–1236.
29. Ellis, S.E.; Coffey, C.S.; Mitchel, E.F., Jr.; Dittus, R.S.; Griffin, M.R. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J. Am. Geriatr. Soc. 2003, 51, 761–767.
30. Walsh, E.E.; Falsey, A.R. Respiratory syncytial virus infection in adult populations. Infect. Disord. Drug Targets 2012, 12, 98–102.
31. Ebbert, J.O.; Limper, A.H. Respiratory syncytial virus pneumonitis in immunocompromised adults: Clinical features and outcome. Respiration 2005, 72, 263–269.
32. Teramoto, S.; Yoshida, K.; Hizawa, N. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir. Investig. 2015, 53, 178–184.
33. Aliberti, S.; Cilloniz, C.; Chalmers, J.D.; Zanaboni, A.M.; Cosentini, R.; Tarsia, P.; Pesci, A.; Blasi, F.; Torres, A. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: A European perspective. Thorax 2013, 68, 997–999.
34. Obed, M.; Garcia-Vidal, C.; Pessacq, P.; Mykietiuk, A.; Viasus, D.; Cazzola, L.; Dominguez, M.; Calmaggi, A.; Carratala, J. Características clínicas y pronóstico de la neumonía adquirida en la comunidad causada por Staphylococcus aureus resistente a meticilina. Enfermedades Infecciosas y Microbiología Clínica 2014, 32, 23–27. (In Spanish)
35. Mandell, L.A.; Wunderink, R.G.; Anzueto, A.; Bartlett, J.G.; Campbell, G.D.; Dean, N.C.; Dowell, S.F.; File, T.M., Jr.; Musher, D.M.; Niederman, M.S.; et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007, 44, S27–S72.
36. Ruiz, L.A.; Gomez, A.; Jaca, C.; Martinez, L.; Gomez, B.; Zalacain, R. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: Incidence, clinical presentation and factors associated with severity during hospital stay. Infection 2010, 38, 453–458.
37. Von Baum, H.; Welte, T.; Marre, R.; Suttorp, N.; Ewig, S. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur. Respir. J. 2010, 35, 598–605.
38. Arancibia, F.; Bauer, T.T.; Torres, A.; Sanchez, F.; Mensa, J.; Maldonado, A.; Rodriguez, M.J.; Ewig, S. Community-acquired Pneumonia caused by Gram-negative bacteria: Incidence and risk and prognosis. Eur. Respir. J. 2016, in press.
39. Torres, A.; Serra, B.J.; Ferrer, A.; Jimenez, P.; Celis, R.; Cobo, E.; Rodriguez, R.R. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am. Rev. Respir. Dis. 1991, 144, 312–318.
40. Cilloniz, C.; Polverino, E.; Ewig, S.; Aliberti, S.; Gabarrus, A.; Menendez, R.; Mensa, J.; Blasi, F.; Torres, A. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 2013, 144, 999–1007.
41. Rello, J.; Bodi, M.; Mariscal, D.; Navarro, M.; Diaz, E.; Gallego, M.; Valles, J. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003, 123, 174–180.
42. Paganin, F.; Lilienthal, F.; Bourdin, A.; Lugagne, N.; Tixier, F.; Genin, R.; Yvin, J.L. Severe community-acquired pneumonia: Assessment of microbial aetiology as mortality factor. Eur. Respir. J. 2004, 24, 779–785.
43. Yoshimoto, A.; Nakamura, H.; Fujimura, M.; Nakao, S. Severe community-acquired pneumonia in an intensive care unit: Risk factors for mortality. Intern. Med. 2005, 44, 710–716.
44. Cilloniz, C.; Gabarrus, A.; Ferrer, M.; Puig de la, B.J.; Rinaudo, M.; Mensa, J.; Niederman, M.S.; Torres, A. Community-Acquired Pneumonia due to Multidrug and non-Multidrug resistant Pseudomonas aeruginosa. Chest 2016, 150, 415–425.
45. Lynch, J.P., III; Zhanel, G.G. Streptococcus pneumoniae: Does antimicrobial resistance matter? Semin. Respir. Crit. Care Med. 2009, 30, 210–238.
46. Song, J.H.; Chung, D.R. Respiratory infections due to drug-resistant bacteria. Infect. Dis. Clin. N. Am. 2010, 24, 639–653.
47. Van, B.F.; Reinert, R.R.; Appelbaum, P.C.; Tulkens, P.M.; Peetermans, W.E. Multidrug-resistant Streptococcus pneumoniae infections: Current and future therapeutic options. Drugs 2007, 67, 2355–2382.
48. Draghi, D.C.; Jones, M.E.; Sahm, D.F.; Tillotson, G.S. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: Findings of the FAST surveillance initiative (2003–2004). Int. J. Antimicrob. Agents 2006, 28, 525–531.
49. Whitney, C.G.; Farley, M.M.; Hadler, J.; Harrison, L.H.; Lexau, C.; Reingold, A.; Lefkowitz, L.; Cieslak, P.; Cetron, M.; Zell, E.R.; et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 2000, 343, 1917–1924.
50. Cilloniz, C.; Albert, R.K.; Liapikou, A.; Gabarrus, A.; Rangel, E.; Bello, S.; Marco, F.; Mensa, J.; Torres, A. The Effect of Macrolide-Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia. Am. J. Respir. Crit. Care Med. 2015, 191, 1265–1272.
51. Kalil, A.C.; Metersky, M.L.; Klompas, M.; Muscedere, J.; Sweeney, D.A.; Palmer, L.B.; Napolitano, L.M.; O’Grady, N.P.; Bartlett, J.G.; Carratala, J.; et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 2016, 63, e61–e111.
52. Chastre, J.; Fagon, J.Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2002, 165, 867–903.
53. Kollef, M.H.; Hamilton, C.W.; Ernst, F.R. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect. Control Hosp. Epidemiol. 2012, 33, 250–256.
54. Restrepo, M.I.; Anzueto, A.; Arroliga, A.C.; Afessa, B.; Atkinson, M.J.; Ho, N.J.; Schinner, R.; Bracken, R.L.; Kollef, M.H. Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect. Control Hosp. Epidemiol. 2010, 31, 509–515.
55. Rello, J.; Ollendorf, D.A.; Oster, G.; Vera-Llonch, M.; Bellm, L.; Redman, R.; Kollef, M.H. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122, 2115–2121.
56. Richards, M.J.; Edwards, J.R.; Culver, D.H.; Gaynes, R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 2000, 21, 510–515.
57. Esperatti, M.; Ferrer, M.; Theessen, A.; Liapikou, A.; Valencia, M.; Saucedo, L.M.; Zavala, E.; Welte, T.; Torres, A. Nosocomial Pneumonia in the Intensive Care Unit Acquired during Mechanical Ventilation or Not. Am. J. Respir. Crit. Care Med. 2010, 182, 1533–1539.
58. Vincent, J.L.; Rello, J.; Marshall, J.; Silva, E.; Anzueto, A.; Martin, C.D.; Moreno, R.; Lipman, J.; Gomersall, C.; Sakr, Y.; et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302, 2323–2329.
59. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171, 388–416.
60. Ewig, S.; Torres, A.; El-Ebiary, M.; Fabregas, N.; Hernández, C.; González, J.; Nicolas, J.M.; Soto, L. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Am. J. Respir. Crit. Care Med. 1999, 159, 188–198.
61. Giantsou, E.; Liratzopoulos, N.; Efraimidou, E.; Panopoulou, M.; Alepopoulou, E.; Kartali-Ktenidou, S.; Minopoulos, G.I.; Zakynthinos, S.; Manolas, K.I. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med. 2005, 31, 1488–1494.
62. Ibrahim, E.H.; Ward, S.; Sherman, G.; Kollef, M.H. A comparative analysis of patients with early-onset vs. late-onset nosocomial pneumonia in the ICU setting. Chest. 2000, 117, 1434–1442.
63. Koulenti, D.; Tsigou, E.; Rello, J. Nosocomial pneumonia in 27 ICUs in Europe: Perspectives from the EU-VAP/CAP study. Eur. J. Clin. Microbiol. Infect. Dis. 2016.
64. Jones, R.N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 2010, 51, S81–S87.
65. Torres, A.; Aznar, R.; Gatell, J.M.; Jiménez, P.; González, J.; Ferrer, A.; Celis, R.; Rodriguez-Roisin, R. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 1990, 142, 523–528.
66. Micek, S.T.; Kollef, M.H.; Torres, A.; Chen, C.; Rello, J.; Chastre, J.; Antonelli, M.; Welte, T.; Clair, B.; Ostermann, H.; et al. Pseudomonas aeruginosa nosocomial pneumonia: Impact of pneumonia classification. Infect. Control Hosp. Epidemiol. 2015, 36, 1190–1197.
67. Nair, G.B.; Niederman, M.S. Nosocomial pneumonia: Lessons learned. Crit. Care Clin. 2013, 29, 521–546.
68. Torres, A.; Carlet, J. Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia. Eur. Respir. J. 2001, 17, 1034–1045.
69. Combes, A.; Figliolini, C.; Trouillet, J.L.; Kassis, N.; Wolff, M.; Gibert, C.; Chastre, J. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002, 121, 1618–1623.
70. Ferrer, M.; Difrancesco, L.F.; Liapikou, A.; Rinaudo, M.; Carbonara, M.; Li, B.G.; Gabarrus, A.; Torres, A. Polymicrobial intensive care unit-acquired pneumonia: Prevalence, microbiology and outcome. Crit. Care 2015, 19, 450.
71. Martin-Loeches, I.; Torres, A.; Rinaudo, M.; Terraneo, S.; de, R.F.; Ramirez, P.; Diaz, E.; Fernandez-Barat, L.; Li Bassi, G.L.; Ferrer, M. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J. Infect. 2015, 70, 213–222.
72. Hohenthal, U.; Sipila, J.; Vainionpaa, R.; Meurman, O.; Rantakokko-Jalava, K.; Nikoskelainen, J.; Kotilainen, P. Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: A study on patients treated in a Finnish university hospital. Scand. J. Infect. Dis. 2004, 36, 198–203.
73. Resti, M.; Micheli, A.; Moriondo, M.; Becciolini, L.; Cortimiglia, M.; Canessa, C.; Indolfi, G.; Bartolini, E.; de, M.M.; Azzari, C. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection. Clin. Ther. 2009, 31, 1266–1273.
74. Liu, Y.F.; Gao, Y.; Chen, M.F.; Cao, B.; Yang, X.H.; Wei, L. Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China. BMC Infect. Dis. 2013, 13, 309.
75. Waterer, G.W.; Wunderink, R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir. Med. 2001, 95, 78–82.
76. Roson, B.; Carratala, J.; Fernandez-Sabe, N.; Tubau, F.; Manresa, F.; Gudiol, F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 2004, 164, 502–508.
77. Andreo, F.; Dominguez, J.; Ruiz-Manzano, J.; Prat, C.; Blanco, S.; Lores, L.; Sanchez, M.D.; Latorre, I.; Gimenez, M.; Ausina, V. Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia. Clin. Microbiol. Infect. 2006, 12, 682–684.
78. Falguera, M.; Lopez, A.; Nogues, A.; Porcel, J.M.; Rubio-Caballero, M. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 2002, 122, 2212–2216.
79. Falguera, M.; Trujillano, J.; Caro, S.; Menendez, R.; Carratala, J.; Ruiz-Gonzalez, A.; Vila, M.; Garcia, M.; Porcel, J.M.; Torres, A. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin. Infect. Dis. 2009, 49, 409–416.
80. Torres, A.; Cilloniz, C.; Ferrer, M.; Gabarrus, A.; Polverino, E.; Villegas, S.; Marco, F.; Mensa, J.; Menendez, R.; Niederman, M. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: Risk and prognosis. Eur. Respir. J. 2015, 45, 1353–1363.
81. Roson, B.; Carratala, J.; Verdaguer, R.; Dorca, J.; Manresa, F.; Gudiol, F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin. Infect. Dis. 2000, 31, 869–874.
82. Anevlavis, S.; Petroglou, N.; Tzavaras, A.; Maltezos, E.; Pneumatikos, I.; Froudarakis, M.; Anevlavis, E.; Bouros, D. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J. Infect. 2009, 59, 83–89.
83. Cook, D.; Mandell, L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117, 195S–197S.
84. Saukkoriipi, A.; Pascal, T.; Palmu, A.A. Evaluation of the BinaxNOW(R) Streptococcus pneumoniae antigen test on fresh, frozen and concentrated urine samples in elderly patients with and without community-acquired pneumonia. J. Microbiol. Methods 2016, 121, 24–26.
85. Schulte, B.; Eickmeyer, H.; Heininger, A.; Juretzek, S.; Karrasch, M.; Denis, O.; Roisin, S.; Pletz, M.W.; Klein, M.; Barth, S.; et al. Detection of pneumonia associated pathogens using a prototype multiplexed pneumonia test in hospitalized patients with severe pneumonia. PLoS ONE 2014, 9, e110566.
86. Scanvic, A.; Courdavault, L.; Sollet, J.P.; Le, T.F. Interest of real-time PCR Xpert MRSA/SA on GeneXpert((R)) DX System in the investigation of staphylococcal bacteremia]. Pathol. Biol. (Paris) 2011, 59, 67–72.
87. Wellinghausen, N.; Siegel, D.; Gebert, S.; Winter, J. Rapid detection of Staphylococcus aureus bacteremia and methicillin resistance by real-time PCR in whole blood samples. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28, 1001–1005.
88. Mok, J.H.; Eom, J.S.; Jo, E.J.; Kim, M.H.; Lee, K.; Kim, K.U.; Park, H.K.; Yi, J.; Lee, M.K. Clinical utility of rapid pathogen identification using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in ventilated patients with pneumonia: A pilot study. Respirology 2016, 21, 321–328.
89. Gadsby, N.J.; Russell, C.D.; McHugh, M.P.; Mark, H.; Conway, M.A.; Laurenson, I.F.; Hill, A.T.; Templeton, K.E. Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin. Infect. Dis. 2016, 62, 817–823.